Assessment of Drug-Drug Interactions of CC-90001, a Potent and Selective Inhibitor of c-Jun N-terminal Kinase (vol 51, pg 1416, 2021)

被引:0
|
作者
Gaudy, Allison
Tong, Zeen
Tatosian, Daniel
Ramirez-Valle, Francisco
Liu, Hong
Chen, Jian
Hoffmann, Matthew
Surapaneni, Sekhar
机构
关键词
D O I
10.1080/00498254.2022.2044178
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:218 / 218
页数:1
相关论文
共 50 条
  • [41] Protein-damaging stresses activate c-jun N-terminal kinase via inhibition of its dephosphorylation: a novel pathway controlled by HSP72 (vol 19, pg 2547, 1999)
    Meriin, AB
    Yaglom, JA
    Gabai, VL
    Zon, L
    Ganiatsas, S
    Mosser, DD
    Sherman, MY
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (07) : 5235 - 5235
  • [42] Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors
    Dou, Xiaodong
    Huang, Huixia
    Jiang, Lan
    Zhu, Guiwang
    Jin, Hongwei
    Jiao, Ning
    Zhang, Liangren
    Liu, Zhenming
    Zhang, Lihe
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 201
  • [43] Tetra-Substituted Pyridinylimidazoles As Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and c-Jun N-Terminal Kinase 3 for Potential Treatment of Neurodegenerative Diseases (vol 58, pg 443, 2015)
    Muth, Felix
    Guenther, Marcel
    Bauer, Silke M.
    Doering, Eva
    Fischer, Sabine
    Maier, Julia
    Drueckes, Peter
    Koeppler, Juergen
    Trappe, Joerg
    Rothbauer, Ulrich
    Koch, Pierre
    Laufer, Stefan A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (05) : 2567 - 2567
  • [44] RETRACTED: Gq Protein-induced Apoptosis Is Mediated by AKT Kinase Inhibition That Leads to Protein Kinase C-induced c-Jun N-terminal Kinase Activation (Retracted article. See vol. 292, pg. 8848, 2017)
    Ben-Ami, Ido
    Yao, Zhong
    Naor, Zvi
    Seger, Rony
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (35) : 31022 - 31031
  • [45] The structure-based optimization of 3-substituted indolin-2-one derivatives as potent and isoform-selective c-Jun N-terminal kinase 3 (JNK3) inhibitors and biological evaluation
    Li, Zhongtang
    Zhu, Guiwang
    Liu, Xiaoang
    Gao, Tongfei
    Fang, Fan
    Dou, Xiaodong
    Li, Yiyan
    Zheng, Ruqiu
    Jin, Hongwei
    Zhang, Liangren
    Liu, Zhenming
    Zhang, Lihe
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 250
  • [46] 2-deoxyglucose inhibits chemotherapeutic drug-induced apoptosis in human monocytic leukemia U937 cells with inhibition of c-Jun N-terminal kinase 1 stress-activated protein kinase activation
    Haga, N
    Naito, M
    Seimiya, H
    Tomida, A
    Dong, J
    Tsuruo, T
    INTERNATIONAL JOURNAL OF CANCER, 1998, 76 (01) : 86 - 90
  • [47] RETRACTION: Preconditioning with pitavastatin, an HMG-CoA reductase inhibitor, attenuates C-Jun N-terminal kinase activation in experimental subarachnoid hemorrhage-induced apoptosis (Retraction of Vol 157, art no 1031, 2015)
    Chang, Chih-Zen
    Wu, Shu-Chuan
    Kwan, Aij-Lie
    Lin, Chih-Lung
    ACTA NEUROCHIRURGICA, 2024, 166 (01)
  • [48] The anticancer plant stress-protein methyl jasmonate induces activation of stress-regulated c-Jun N-terminal kinase and p38 protein kinase in human lymphoid cells (vol 17, pg 2230, 2003)
    Rotem, R
    Fingrut, O
    Moskovitz, J
    Flescher, E
    LEUKEMIA, 2004, 18 (02) : 374 - 374
  • [49] Multistage Screening Reveals 3-Substituted lndolin-2-one Derivatives as Novel and Isoform-Selective c-Jun N-terminal Kinase 3 (JNK3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases
    Dou, Xiaodong
    Huang, Huixia
    Li, Yibo
    Jiang, Lan
    Wang, Yanxing
    Jin, Hongwei
    Jiao, Ning
    Zhang, Lihe
    Zhang, Liangren
    Liu, Zhenming
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (14) : 6645 - 6664